Content related to Project Could Transform Clinical Trials for Pediatric Brain Tumors

After her son was diagnosed with a rare tumor, Melissa searched for help. She found it at CHLA in the office of Dr. Ashley Margol, one of the few experts in an innovative therapy called MEMMAT.

Jonathan Santoro, MD, is pioneering a novel treatment—and the first clinical trial— for Down syndrome regression disorder, a devastating condition in young people with Down syndrome.

The trial is studying a potential treatment for Dup15q and incorporates an EEG biomarker established by CHLA researchers.

Four investigators share their research—and how the USC/CHLA facility will help bring novel cell therapies to clinical trials faster.

Dr. Shafali Jeste at Children’s Hospital Los Angeles is seeking biomarkers that can address the incredible variability of autism, an important step toward developing targeted treatments.

Five important questions that parents should ask about participating in a cancer clinical trial.

A Children’s Hospital Los Angeles endocrinologist shares her thoughts on why the newly released pediatric obesity guidelines were urgently needed.

A Children’s Hospital Los Angeles expert shares the latest on tuberous sclerosis complex care and research.

Investigators are exploring a novel use for nanoparticles: enhancing radiation therapy for an aggressive childhood brain tumor.